Expression of Nuclear Factor-κB and Its Clinical Significance in Nonsmall-Cell Lung Cancer

Zhenfa Zhang,Jianqun Ma,Ni Li,Nan Sun,Changli Wang

DOI: https://doi.org/10.1016/j.athoracsur.2006.01.049

IF: 5.113

2006-01-01

The Annals of Thoracic Surgery

Abstract:Background. It has been known that transcription factor nuclear factor (NF)-kappa B plays an important role in cell proliferation and oncogenesis. The aims of this study were to evaluate expression levels of NF-kappa B in nonsmall-cell lung cancer (NSCLC) and to elucidate its clinical significance and prognostic value for patients with NSCLC. Methods. Using 45 tumor tissue specimens from 45 patients with NSCLC who underwent surgery, we investigated the expression of NF-kappa B using Western blotting analysis. Apoptotic rate of NSCLC cells with different expression of NF-kappa B was determined by TUNEL (terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end-labeling) assay. Paraffin-embedded tissue blocks from 71 consecutive patients with NSCLC were obtained for immunohistochemical staining. Results. The expression level of NF-kappa B in poorly or moderately differentiated lung cancer cells was higher than that in well-differentiated ones (p = 0.001). The apoptotic rate was lower for lung cancer cells with higher NF-kappa B expression than for those with lower NF-kappa B expression (p = 0.0238). Furthermore, expression of NF-kappa B was correlated with caspase-3, cyclooxygenase-2, and p53 expression in lung cancer cells that were examined. Most NSCLC cells showed nuclear staining pattern and the nuclear positive rate was 67.6% (48 of 71 specimens). Immunohistochemical NF-kappa B expression in patients with NSCLC was an independent prognostic factor for overall survival. Conclusions. The results of this study suggest that expression of NF-kappa B may correlate with lung cancer differentiation. Overexpression of NF-kappa B inhibits tumor cell apoptosis and indicates an unfavorable prognosis for overall survival in some patients with NSCLC.